Sponsor study identifier
Secondary identifiers
observational
0
1 country
1
Study Start
January 2010
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
January 2099
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
January 2099
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
We have an active research program in gastrointestinal cancers including clinical trials, epidemiologic, and translational studies. We would like to establish a biospecimen bank linked to useful clinical information in order to learn more about diagnostic, predictive and prognostic markers for gastrointestinal cancers. PRIMARY OBJECTIVES: 1\. To collect and store tumor and normal tissue (previously collected paraffin embedded or frozen specimen) and blood in patients with gastrointestinal (GI) cancers. SECONDARY OBJECTIVES:
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
January 2099
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
December 10, 2009
Actual (reported)December 14, 2009
Actual (reported)January 2010
Date type not reportedThis date has not been verified as actual or estimated.
January 2099
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
January 2099
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
None: Biospecimen will be collected for future research.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Patients with gastrointestinal cancer.
Contact the study team to confirm eligibility.
Stanford University School of Medicine
Stanford, California, 94305, United States
This study requires that we obtain archived tumor and normal tissue and blood.
Teri A Longacre M.D.
Stanford University
0 participants (actual enrollment reported by the registry).
First Submitted
December 10, 2009
First Posted
December 14, 2009
Study Start
January 2010
Date type not reportedThis date has not been verified as actual or estimated.
Integrated Whole-Genome Analysis of Hematologic Disorders
Primary Completion
January 2099
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
January 2099
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Last Updated
May 28, 2012
Record last verified: 2012-05
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: